Sacubitril valsartan altenating from keeping ACE-I/ARB in Heart Failure Study

Sacubitril valsartan altenating from keeping ACE-I/ARB in Heart Failure Study - SAKAI-HF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045300

Enrollment

100

Registered

2021-09-01

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic heart failure with ACE-I or ARB

Exclusion criteria

Exclusion criteria: acute heart failure

Design outcomes

Primary

Measure	Time frame
LVEF at TTE	—

Secondary

Measure	Time frame
other echocardiographic findings, laboratory data	—

Countries

Japan

Contacts

Public ContactShodai Kawanami

Osaka Rosai Hospital cardiology

junnai-hisho@osakah.johas.go.jp072-252-3561

Outcome results